Potential participants will be identified primarily through NGOs and primary care teams, all designated as Participant Information Agencies (PIAs). PIAs will be provided with a short summary of the study including the main inclusion and exclusion criteria. They will be asked to display posters and leaflets and discuss the study opportunistically with AS&Rs who access the services. All participant-facing documentation will have the necessary approvals from a Research Ethics Committee (REC).
Potential participants will be made known to the research team via one of the following methods:
By them contacting the research team directly via telephone or email
By agreeing to their details being given to the research team (via a participant recommendation form, completed by the PIA with the AS&R, and returned to the research team by the PIA)
By attending a researcher-attended drop-in session at collaborating NGOs on a specific date/time, advertised by posters/leaflets/verbally
Following identification of a potential participant, a postdoctoral researcher based in the University of Liverpool, who is trained in the PROSPER trial techniques and in discussion about informed consent, will arrange a meeting to give more information about the trial.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.